Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma.
Folprecht G, Lutz MP, Schöffski P, Seufferlein T, Nolting A, Pollert P, Köhne CH. Folprecht G, et al. Among authors: seufferlein t. Ann Oncol. 2006 Mar;17(3):450-6. doi: 10.1093/annonc/mdj084. Epub 2005 Nov 22. Ann Oncol. 2006. PMID: 16303861 Free article. Clinical Trial.
Palliative treatment of pancreatic cancer.
von Wichert G, Seufferlein T, Adler G. von Wichert G, et al. Among authors: seufferlein t. J Dig Dis. 2008 Feb;9(1):1-7. doi: 10.1111/j.1443-9573.2007.00314.x. J Dig Dis. 2008. PMID: 18251787 Review.
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group.
Arnold D, Höhler T, Dittrich C, Lordick F, Seufferlein T, Riemann J, Wöll E, Herrmann T, Zubel A, Schmoll HJ. Arnold D, et al. Among authors: seufferlein t. Ann Oncol. 2008 Aug;19(8):1442-1449. doi: 10.1093/annonc/mdn150. Epub 2008 Apr 25. Ann Oncol. 2008. PMID: 18441330 Free article. Clinical Trial.
Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205.
Hoehler T, von Wichert G, Schimanski C, Kanzler S, Moehler MH, Hinke A, Seufferlein T, Siebler J, Hochhaus A, Arnold D, Hallek M, Hofheinz R, Hacker UT. Hoehler T, et al. Among authors: seufferlein t. Br J Cancer. 2013 Sep 17;109(6):1408-13. doi: 10.1038/bjc.2013.409. Epub 2013 Aug 20. Br J Cancer. 2013. PMID: 23963139 Free PMC article. Clinical Trial.
Smarter drugs emerging in pancreatic cancer therapy.
Kleger A, Perkhofer L, Seufferlein T. Kleger A, et al. Among authors: seufferlein t. Ann Oncol. 2014 Jul;25(7):1260-1270. doi: 10.1093/annonc/mdu013. Epub 2014 Mar 14. Ann Oncol. 2014. PMID: 24631947 Free article. Review.
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardière C, Boucher E, Fartoux L, Faivre S, Blanc JF, Viret F, Assenat E, Seufferlein T, Herrmann T, Grenier J, Hammel P, Dollinger M, André T, Hahn P, Heinemann V, Rousseau V, Ducreux M, Pignon JP, Wendum D, Rosmorduc O, Greten TF; BINGO investigators. Malka D, et al. Among authors: seufferlein t. Lancet Oncol. 2014 Jul;15(8):819-28. doi: 10.1016/S1470-2045(14)70212-8. Epub 2014 May 19. Lancet Oncol. 2014. PMID: 24852116 Free PMC article. Clinical Trial.
Treatment sequence of synchronously (liver) metastasized colon cancer.
Gruenberger T, Beets G, Van Laethem JL, Rougier P, Cervantes A, Douillard JY, Figueras J, Gruenberger B, Haller DG, Labianca R, Maleux G, Roth A, Ducreux M, Schmiegel W, Seufferlein T, Van Cutsem E. Gruenberger T, et al. Among authors: seufferlein t. Dig Liver Dis. 2016 Oct;48(10):1119-23. doi: 10.1016/j.dld.2016.06.009. Epub 2016 Jun 17. Dig Liver Dis. 2016. PMID: 27375207 Review.
442 results